Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M348Revenue (TTM) $M356Net Margin (%)49.0Altman Z-Score2.8
Enterprise Value $M397EPS (TTM) $1.1Operating Margin %83.9Piotroski F-Score3
P/E(ttm)2.0Beneish M-Score-3.1Pre-tax Margin (%)80.6Higher ROA y-yN
Price/Book0.510-y EBITDA Growth Rate %24.6Quick Ratio2.9Cash flow > EarningsN
Price/Sales1.05-y EBITDA Growth Rate %23.0Current Ratio2.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-35.6ROA % (ttm)16.3Higher Current Ratio y-yN
Dividend Yield %11.9PEG0.1ROE % (ttm)24.8Less Shares Outstanding y-yN
Payout Ratio %24.0Shares Outstanding M166ROIC % (ttm)24.1Gross Margin Increase y-yN

Gurus Latest Trades with PDLI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PDLIJoel Greenblatt 2016-09-30 Reduce-0.04%$2.72 - $3.57
($3.17)
$ 2.10-34%Reduce -44.80%1,266,121
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-09-30 Add$2.72 - $3.57
($3.17)
$ 2.10-34%Add 0.71%299,285
PDLIJoel Greenblatt 2016-06-30 Reduce-0.05%$2.95 - $3.82
($3.33)
$ 2.10-37%Reduce -38.56%2,293,523
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-06-30 Reduce$2.95 - $3.82
($3.33)
$ 2.10-37%Reduce -0.36%297,175
PDLIJoel Greenblatt 2016-03-31 Reduce-0.04%$2.75 - $3.54
($3.12)
$ 2.10-33%Reduce -21.40%3,732,679
PDLIBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Add$2.75 - $3.54
($3.12)
$ 2.10-33%Add 5.86%298,243
PDLIJoel Greenblatt 2015-12-31 Reduce-0.01%$3.5 - $5.26
($4.16)
$ 2.10-50%Reduce -5.90%4,748,690
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Add$3.5 - $5.26
($4.16)
$ 2.10-50%Add 1.90%281,746
PDLIJoel Greenblatt 2015-09-30 Reduce-0.12%$4.95 - $6.56
($5.73)
$ 2.10-63%Reduce -30.24%5,046,353
PDLIJoel Greenblatt 2015-06-30 Add0.21%$6.23 - $7.3
($6.7)
$ 2.10-69%Add 114.94%7,233,838
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-06-30 Add$6.23 - $7.3
($6.7)
$ 2.10-69%Add 5.41%276,491
PDLIJoel Greenblatt 2015-03-31 Add0.17%$6.7 - $7.72
($7.24)
$ 2.10-71%Add 1739.03%3,365,474
PDLIBarrow, Hanley, Mewhinney & Strauss 2015-03-31 Buy $6.7 - $7.72
($7.24)
$ 2.10-71%New holding262,299
PDLIJoel Greenblatt 2014-12-31 Add0.01%$7.325 - $8.53
($7.92)
$ 2.10-73%Add 603.94%183,003
PDLIJoel Greenblatt 2014-09-30 Reduce-0.09%$7.51 - $10.26
($9.3)
$ 2.10-77%Reduce -96.71%25,997
PDLIJoel Greenblatt 2014-06-30 Reduce-0.11%$8 - $9.85
($8.9)
$ 2.10-76%Reduce -52.58%789,804
PDLIJoel Greenblatt 2014-03-31 Reduce-0.34%$7.46 - $9.14
($8.57)
$ 2.10-75%Reduce -50.19%1,665,543
PDLIJoel Greenblatt 2013-09-30 Add0.15%$7.72 - $8.44
($8.04)
$ 2.10-74%Add 24.84%2,890,564
PDLIJoel Greenblatt 2013-03-31 Add0.15%$6.65 - $7.53
($7.08)
$ 2.10-70%Add 23.50%2,135,460
PDLIJoel Greenblatt 2012-12-31 Add0.59%$7.09 - $8.37
($7.75)
$ 2.10-73%Add 561.89%1,729,133
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PDLI is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PDLI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GARCIA PETER SVice President, CFO 2016-08-09Buy10,000$3-30view
GARCIA PETER SVice President, CFO 2015-12-15Buy15,000$3.5-40view
Pietzke SteffenController and CAO 2015-12-07Buy20,590$3.64-42.31view
GARCIA PETER SVice President, CFO 2015-08-14Buy20,000$5.83-63.98view
SELICK HAROLD EDirector 2014-11-26Buy6,000$8.08-74.01view
Lindell Jody SDirector 2011-03-15Buy374$5.33-60.6view
LARSON CHRISTINE RVice President and CFO 2010-05-14Buy5,000$5.71-63.22view
LARSON CHRISTINE RVice President and CFO 2010-04-30Buy10,000$6.18-66.02view
KLEIN JOSEPH IIIDirector 2009-11-04Sell24,000$8.33-74.79view
Lindell Jody SDirector 2009-06-15Buy3,000$7.76-72.94view

Press Releases about PDLI :

Quarterly/Annual Reports about PDLI:

News about PDLI:

Articles On GuruFocus.com
Medical Companies Offer Good Value Opportunities Sep 16 2016 
Undervalued Companies With Growing EPS Apr 04 2016 
Cash is Flowing Nicely for These Five Stocks Aug 19 2015 
Context Capital Management's Top Buys in Q2 2015 Jul 15 2015 
Weekly 3-Year Low Highlights: APOL, PDLI, TC, ALLT, ELRC May 17 2015 
Hot Picks with High Yields Jul 23 2013 
My 3 Favorite Healthcare Dividend Stocks with Highest Float Short Ratio Jun 03 2013 
My 4 Favorites From The 20 Cheapest Healthcare Dividend Stock List May 02 2013 
68 Top-Yielding Stocks with Ex-Dividend Date in March 2013 Feb 27 2013 
20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013 

More From Other Websites
Is PDL BioPharma Inc (PDLI) Going to Burn These Hedge Funds? Dec 02 2016
Fitbit, Vodafone Sink into Tuesday’s 52-Week Low Club Nov 29 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 29 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Nov 28 2016
Vodafone, Towerstream Slide into Monday’s 52-Week Low Club Nov 28 2016
ETFs with exposure to PDL BioPharma, Inc. : November 23, 2016 Nov 23 2016
PDL BioPharma Issues $150.0 Million of 2.75% Convertible Senior Notes Due 2021 Nov 22 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered... Nov 22 2016
PDL BioPharma Issues $150.0 Million of 2.75% Convertible Senior Notes Due 2021 Nov 22 2016
PDL BioPharma, Inc. :PDLI-US: Earnings Analysis: Q3, 2016 By the Numbers : November 22, 2016 Nov 22 2016
PDL BioPharma to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 22 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 17 2016
PDL BioPharma Prices Public Offering of $150.0 Million of 2.75% Convertible Senior Notes Due 2021 Nov 17 2016
PDL BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : PDLI-US : November 17,... Nov 17 2016
PDL BIOPHARMA, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 15 2016
PDL BioPharma Announces Proposed $150 Million Public Offering of New Convertible Senior Notes Due... Nov 15 2016
PDL BioPharma Announces Proposed $150 Million Public Offering of New Convertible Senior Notes Due... Nov 15 2016
PDL BIOPHARMA, INC. Financials Nov 11 2016
PDL BioPharma (PDLI) Q3 Earnings Lag, Revenues Fall Y/Y Nov 07 2016
PDL BioPharma posts 3Q profit Nov 03 2016
PDL BioPharma Announces Third Quarter 2016 Financial Results Nov 03 2016
PDL BioPharma to Announce Third Quarter 2016 Financial Results on November 3, 2016 Oct 27 2016
PDL BioPharma Announces the Successful Conclusion of its Debt Financing Agreement with Paradigm... Aug 29 2016
PDL BioPharma posts 2Q profit Aug 04 2016
PDL BioPharma Announces Second Quarter 2016 Financial Results Aug 04 2016
PDL BioPharma Announces Elimination of Quarterly Cash Dividend Aug 04 2016
PDL BioPharma Completes Second Tranche Payment Under Royalty Transaction with ARIAD Pharmaceuticals Aug 01 2016
PDL BioPharma to Announce Second Quarter 2016 Financial Results on August 4, 2016 Jul 28 2016
PDL BioPharma Closes Equity Investment Transaction in Noden Pharma for the Acquisition of Tekturna®... Jul 06 2016
PDL BioPharma Completes Quarterly Dividend Payment Jun 13 2016
PDL BioPharma to Present at the Jefferies 2016 Healthcare Conference Jun 01 2016
PDL BioPharma Commits to Equity Investment in Noden Pharma for the Acquisition of Tekturna®... May 24 2016
PDL BioPharma posts 1Q profit May 04 2016
PDL BioPharma Announces 2016 Second Quarter Dividend May 04 2016
PDL BioPharma Announces First Quarter 2016 Financial Results May 04 2016
PDL BioPharma to Announce First Quarter 2016 Financial Results on May 4, 2016 Apr 28 2016
PDL BioPharma to Hold Annual Meeting of Stockholders on June 2, 2016 Mar 31 2016
PDL BioPharma posts 4Q profit Feb 22 2016
PDL BioPharma Announces 2016 First Quarter Dividend Feb 01 2016
PDL BioPharma Announces Closing of Transaction Related to LENSAR Debt Investment Dec 17 2015
PDL BioPharma Completes Regular Quarterly Dividend Payment Dec 14 2015
PDL BioPharma posts 3Q profit Nov 04 2015
PDL BioPharma posts 2Q profit Aug 05 2015
PDL BioPharma posts 1Q profit May 06 2015
PDL BioPharma posts 3Q profit Nov 10 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)